Company intelligence / Profile preview

Sanguina

Peachtree Corners, Georgia, United States

Ownership: Private
Employees: ~34
Development stage: Other

Overview

Sanguina’s AnemoCheck Home is the only FDA-cleared home hemoglobin test in the US; clinical studies have validated its efficacy for anemia screening and management. Ruby expands the offering to overall blood health monitoring by adding circulation analysis, hydration tracking, and other wellness features

Therapeutic areas: CardiovascularHematology
Modalities: Device (mobile app)Diagnostic test (point-of-care test, over-the-counter kit)
Industry: Protein Biomarker Diagnostics

Partnerships

Georgia Institute of TechnologyEmory UniversityChildren's Healthcare of AtlantaCenters for Disease Control and Prevention (CDC)Investment from Veritus Holdings, The Seed Lab

Beyond the preview

Go deeper on Sanguina.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanguina.

Explore the full profile